Sarno S - Search Results

1

New potential peptide therapeutics perturbing CK1δ/α-tubulin interaction.

Krüger M, Kalbacher H, Kastritis PL, Bischof J, Barth H, Henne-Bruns D, Vorgias C, Sarno S, Pinna LA, Knippschild U. Krüger M, et al. Among authors: sarno s. Cancer Lett. 2016 Jun 1;375(2):375-383. doi: 10.1016/j.canlet.2016.03.021. Epub 2016 Mar 17. Cancer Lett. 2016. PMID: 26996302

2

Modulation of protein kinase CK2 activity by fragments of CFTR encompassing F508 may reflect functional links with cystic fibrosis pathogenesis.

Pagano MA, Arrigoni G, Marin O, Sarno S, Meggio F, Treharne KJ, Mehta A, Pinna LA. Pagano MA, et al. Among authors: sarno s. Biochemistry. 2008 Jul 29;47(30):7925-36. doi: 10.1021/bi800316z. Epub 2008 Jul 3. Biochemistry. 2008. PMID: 18597485 Free PMC article.

3

Protein kinase CK2 as a druggable target.

Sarno S, Pinna LA. Sarno S, et al. Mol Biosyst. 2008 Sep;4(9):889-94. doi: 10.1039/b805534c. Epub 2008 Jun 12. Mol Biosyst. 2008. PMID: 18704226 Review.

4

Superiority of PLK-2 as α-synuclein phosphorylating agent relies on unique specificity determinants.

Salvi M, Trashi E, Marin O, Negro A, Sarno S, Pinna LA. Salvi M, et al. Among authors: sarno s. Biochem Biophys Res Commun. 2012 Feb 3;418(1):156-60. doi: 10.1016/j.bbrc.2011.12.152. Epub 2012 Jan 10. Biochem Biophys Res Commun. 2012. PMID: 22248692

5

Design, validation and efficacy of bisubstrate inhibitors specifically affecting ecto-CK2 kinase activity.

Cozza G, Zanin S, Sarno S, Costa E, Girardi C, Ribaudo G, Salvi M, Zagotto G, Ruzzene M, Pinna LA. Cozza G, et al. Among authors: sarno s. Biochem J. 2015 Nov 1;471(3):415-30. doi: 10.1042/BJ20141127. Epub 2015 Sep 8. Biochem J. 2015. PMID: 26349539

6

Selectivity of 4,5,6,7-tetrabromobenzotriazole, an ATP site-directed inhibitor of protein kinase CK2 ('casein kinase-2').

Sarno S, Reddy H, Meggio F, Ruzzene M, Davies SP, Donella-Deana A, Shugar D, Pinna LA. Sarno S, et al. FEBS Lett. 2001 May 4;496(1):44-8. doi: 10.1016/s0014-5793(01)02404-8. FEBS Lett. 2001. PMID: 11343704 Free article.

7

Unique activation mechanism of protein kinase CK2. The N-terminal segment is essential for constitutive activity of the catalytic subunit but not of the holoenzyme.

Sarno S, Ghisellini P, Pinna LA. Sarno S, et al. J Biol Chem. 2002 Jun 21;277(25):22509-14. doi: 10.1074/jbc.M200486200. Epub 2002 Apr 15. J Biol Chem. 2002. PMID: 11956194 Free article.

8

Exploiting the repertoire of CK2 inhibitors to target DYRK and PIM kinases.

Cozza G, Sarno S, Ruzzene M, Girardi C, Orzeszko A, Kazimierczuk Z, Zagotto G, Bonaiuto E, Di Paolo ML, Pinna LA. Cozza G, et al. Among authors: sarno s. Biochim Biophys Acta. 2013 Jul;1834(7):1402-9. doi: 10.1016/j.bbapap.2013.01.018. Epub 2013 Jan 27. Biochim Biophys Acta. 2013. PMID: 23360763

9

Cell-permeable dual inhibitors of protein kinases CK2 and PIM-1: structural features and pharmacological potential.

Cozza G, Girardi C, Ranchio A, Lolli G, Sarno S, Orzeszko A, Kazimierczuk Z, Battistutta R, Ruzzene M, Pinna LA. Cozza G, et al. Among authors: sarno s. Cell Mol Life Sci. 2014 Aug;71(16):3173-85. doi: 10.1007/s00018-013-1552-5. Epub 2014 Jan 18. Cell Mol Life Sci. 2014. PMID: 24442476

10

The Selectivity of CK2 Inhibitor Quinalizarin: A Reevaluation.

Cozza G, Venerando A, Sarno S, Pinna LA. Cozza G, et al. Among authors: sarno s. Biomed Res Int. 2015;2015:734127. doi: 10.1155/2015/734127. Epub 2015 Oct 19. Biomed Res Int. 2015. PMID: 26558278 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

167 results

Search Page